U.S., Oct. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07219277) titled 'Clinical Validation of Early Detection Blood Test for Universal Large-scale Breast Cancer Screening' on Oct. 15.
Brief Summary: Breast cancer is the most common cancer that spreads beyond the initial layer of tissue it developed in, and grows into surrounding healthy tissue in women worldwide. It is associated with significant illness and death. Identifying the disease in the early stage is important to achieving positive outcomes in response to diagnosis and treatment.
The Syantra blood test has been developed over the past 10 years. This test involves examining blood samples to identify and analyze specific information. This info...